ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N07BC51 | G | Buprenorphine - 8mg, Naloxone HCl - 2mg | 11407 | 6322/1 | BUPENSAN DUO | 8mg | 7 | Tablet | Sublingual | Bellapharma S.A.R.L. | GL Pharma GmbH | Austria | 5,912,907 L.L | 23.08 | B | GL Pharma GmbH | Austria | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N07BC51 | G | Buprenorphine HCl - 8mg, Naloxone HCl - 2mg | 9554 | 86318/1 | SUBOXONE | 28 | Tablet, sublingual | Oral | Minapharm Halabi | Reckitt Benckiser Healthcare (UK) Ltd | UK | 7,382,584 L.L | 21.26 | C | Indivior (UK) Ltd | UK | 2/5/2024 | 0 |